Information:
Error:
ID
26678
Description
Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Medical Conditions
Keywords
Versions (2)
- 8/27/17 8/27/17 -
- 10/23/17 10/23/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
October 23, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Medical Conditions GSK study Chronic Coronary Heart Disease NCT00799903
Medical Conditions GSK study Chronic Coronary Heart Disease NCT00799903
Similar models
Medical Conditions GSK study Chronic Coronary Heart Disease NCT00799903
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item
1. Prior myocardial infarction [>1 month prior to randomisation]
integer
Code List
1. Prior myocardial infarction [>1 month prior to randomisation]
CL Item
Current (1)
CL Item
No medical condition (5)
Myocardial infarction, date of diagnosis
Item
Date of diagnosis
date
Item
2. Percutaneous coronary intervention (PCI) [>1 month prior to randomisation]
integer
Code List
2. Percutaneous coronary intervention (PCI) [>1 month prior to randomisation]
CL Item
Current (1)
CL Item
No medical condition (5)
PCI, date of diagnosis
Item
Date of diagnosis
date
Item
3. Coronary artery bypass graft (CABG) [>3 months prior to randomisation]
integer
Code List
3. Coronary artery bypass graft (CABG) [>3 months prior to randomisation]
CL Item
Current (1)
CL Item
No medical condition (5)
CABG date of diagnosis
Item
Date of diagnosis
date
Item
4. Multivessel coronary heart disease confirmed by angiography (without revascularization)
integer
Code List
4. Multivessel coronary heart disease confirmed by angiography (without revascularization)
CL Item
Current (1)
CL Item
No medical condition (5)
Multivessel coronary heart disease, date of diagnosis
Item
Date of diagnosis
date
CL Item
Current (1)
CL Item
No medical condition (5)
Type I diabetes mellitus, date of diagnosis
Item
Date of diagnosis
date
CL Item
Current (1)
CL Item
No medical condition (5)
Type II diabetes mellitus, date of diagnosis
Item
Date of diagnosis
date
Item Group
Additional predictors of cardiovascular risk
CL Item
Current (1)
CL Item
No medical condition (5)
HDL Cholesterol, date of diagnosis
Item
Date of diagnosis
date
Item
8. Significant renal dysfunction based on/confirmed by estimated glomerular filtration rate [>30 and <59 mL/min per 1.73 m2]
integer
Code List
8. Significant renal dysfunction based on/confirmed by estimated glomerular filtration rate [>30 and <59 mL/min per 1.73 m2]
CL Item
Current (1)
CL Item
No medical condition (5)
Renal dysfunction eGFR, date of diagnosis
Item
Date of diagnosis
date
Item
9. Renal dysfunction based on/confirmed by urine albumin:creatinine ratio (ACR) [>30 mg albumin/g creatinine]
integer
Code List
9. Renal dysfunction based on/confirmed by urine albumin:creatinine ratio (ACR) [>30 mg albumin/g creatinine]
CL Item
Current (1)
CL Item
No medical condition (5)
Renal dysfunction ACR, date of diagnosis
Item
Date of diagnosis
date
CL Item
Current (1)
CL Item
No medical condition (5)
Carotid artery Stenosis, date of diagnosis
Item
Date of diagnosis
date
CL Item
Current (1)
CL Item
No medical condition (5)
Carotid artery stenting, date of diagnosis
Item
Date of diagnosis
date
CL Item
Current (1)
CL Item
No medical condition (5)
Carotid artery surgery, date of diagnosis
Item
Date of diagnosis
date
CL Item
Current (1)
CL Item
No medical condition (5)
ischaemic stroke, date of diagnosis
Item
Date of diagnosis
date
Item
14. Intermittent claudication [with objective evidence of vascular origin]
integer
Code List
14. Intermittent claudication [with objective evidence of vascular origin]
CL Item
Current (1)
CL Item
No medical condition (5)
Intermittent claudication, date of diagnosis
Item
Date of diagnosis
date
CL Item
Current (1)
CL Item
No medical condition (5)
Peripheral arterial stenting, date of diagnosis
Item
Date of diagnosis
date
CL Item
Current (1)
CL Item
No medical condition (5)
Peripheral artery surgery, date of diagnosis
Item
Date of diagnosis
date
Item
17. Peripheral artery disease with amputation
integer
CL Item
Current (1)
CL Item
No medical condition (5)
Peripheral artery disease with amputation, date of diagnosis
Item
Date of diagnosis
date
Item
18. Ankle brachial index decreased [<0.9 in at least one ankle]
integer
Code List
18. Ankle brachial index decreased [<0.9 in at least one ankle]
CL Item
Current (1)
CL Item
No medical condition (5)
Ankle brachial index decreased, date of dignosis
Item
Date of dignosis
date